Factor VII anticorps (C-Term, Phe7)
Aperçu rapide pour Factor VII anticorps (C-Term, Phe7) (ABIN2235832)
Antigène
Voir toutes Factor VII (F7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term, Phe7
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Coagulation factor VII (F7) (SPCA, eptacog alfa, factor VII, FVII coagulation protein, Proconvertin, Serum prothrombin conversion accelerator, , INN)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the C-terminal of human F7.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C/-20°C
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
Autre désignation
- Coagulation Factor VII
-
UniProt
- P08709
-
Pathways
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Antigène
-